HTC VIVE Technology Used in Penumbra’s REAL Immersive System for Stroke Patient Recovery

REAL™ Immersive System Uses HTC VIVE Focus™ and Animated Content to Provide Rehabilitation to Stroke Patients

REAL™ Immersive System (REAL System) is using a custom-designed VIVE Focus™ head-mounted display to help patients recover from stroke and other neurological injuries.

Penumbra reports evidence shows that rehabilitation can help survivors of neurological injury, such as those due to stroke or trauma, recover their abilities. Rehabilitation drives neuroplasticity, or the brain’s ability to reorganize itself by forming new connections. However, research has shown that only 30% of patients ever attend rehabilitation. And even if they do attend, the average amount of days spent rehabilitating using traditional methods is less than optimum. Created by Penumbra, and using Vive VR technology, the REAL System places patients into an animated world with therapeutic experiences designed to increase neuroplasticity through patient engagement and retention.

“When it comes to patients who have suffered neurological injury, there are very real barriers to overcome in the rehabilitation process,” said Dan O’Brien, HTC Global Head of Enterprise. “We’re excited the Vive Focus can help by providing the power and portability for clinicians to treat patients outside of traditional settings with the REAL System.”

The REAL System is a portable VR rehabilitation solution for upper-extremity rehabilitation that can be used at the patient’s bedside, in a therapy gym, or in a mobile health location. The three main components of the system include the Vive Focus headset, a set of six sensors, and a tablet with the TherapyView™ app that allows the clinician to administer and monitor the therapy session.

Upon powering on, the patient is immediately immersed in VR, engaging in visual and physical challenges guided by their therapist. Body sensors are attached with soft neoprene bands, and in less than two minutes of set-up time, the patient is working in a virtual world with their full-presence avatar. The therapist can see what the patient sees on an included tablet interface, which the therapist uses to select various activities, adjust activity parameters, and monitor the patient’s experience at the tap of a button. Data from the patient’s movement and accomplishments is securely saved so that documentation is easy to produce, and long-term trending can guide the patient’s recovery.

Vive Focus is HTC’s signature standalone headset for enterprises. The high-resolution dual 3K AMOLED screens and Qualcomm® Snapdragon™ 835 processor enables patients to enjoy real-time feedback and interaction with Penumbra’s content, while the wireless headset ensures patients can move freely. Penumbra worked closely with HTC to customize the headset specifically for rehabilitation patients, ensuring that it had the proper weight, fit and comfort.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version